Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-24

FDA Approved: LORATADINE — Original Application (Aurohealth LLC)

View source ↗

Summary

The FDA approved Aurohealth LLC's original application for loratadine, a generic antihistamine. It covers indications for allergic rhinitis and urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)

Snippet

ORIG AP for LORATADINE (LORATADINE)